Anti-diabetic effects of resveratrol (lowering of FBG, elevated GSIS, and improvements in circulating insulin levels) have been noted in rodent models of hyperglycemia, glucose intolerance, and T2DM [165–167]. Here, INS is linked to Glucose intolerance.